Background The effect of inhaled corticosteroids (ICS) on fracture risk in patients with
chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study was …

Context Recent studies of inhaled corticosteroid (ICS) therapy for managing stable chronic
obstructive pulmonary disease (COPD) have yielded conflicting results regarding survival …

Background Significant adverse effects (AEs) have been associated with continuous
exposure to oral corticosteroids (OCSs). The potential association with intermittent exposure …

Background The current Global initiative for chronic Obstructive Lung Disease (GOLD)
treatment strategy recommends the use of one or more bronchodilators according to the …

The Global Initiative for Asthma guidelines use the traditional terminology of “low,”“medium,”
and “high” doses of inhaled corticosteroids (ICS) to define daily maintenance doses of 100 …

Background Real-world prescription pathways leading to triple therapy (TT)(inhaled
corticosteroid [ICS] plus long-acting β2-agonist bronchodilator [LABA] plus long-acting …

In this article, we focus on the scientific evidence from randomised trials supporting
treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …

Glucocorticoids remain a cornerstone of guideline-based management of persistent asthma
and allergic diseases. Glucocorticoid-induced osteoporosis (GIO) is the most common …

The Indacaterol: Switching Non-exacerbating Patients with Moderate COPD From
Salmeterol/Fluticasone to Indacaterol (INSTEAD) study investigated the effect of switching …

In recent years, there has been a significant increase in media coverage of the putative
actions of vitamin D as well as the possible health benefits that supplementation might …